CAR-NK Cells in the Treatment of Solid Tumors

CAR-T (chimeric antigen receptor T) cells have emerged as a milestone in the treatment of patients with refractory B-cell neoplasms. However, despite having unprecedented efficacy against hematological malignancies, the treatment is far from flawless. Its greatest drawbacks arise from a challenging...

Descripción completa

Detalles Bibliográficos
Autores principales: Wrona, Ewa, Borowiec, Maciej, Potemski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197981/
https://www.ncbi.nlm.nih.gov/pubmed/34072732
http://dx.doi.org/10.3390/ijms22115899